University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 10 of 23
Assessment of Stability of Behavioral and Neural Measures of Attention Networks Across Multiple Sessions
NCT04033731
Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies
NCT03718429
Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma
NCT03658304
Characterizing the Effects of Family History of Alcoholism on Alcohol Analgesia
NCT04925076
A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care
NCT03407417
Prenatal Breast Pump Education of Mothers and Their Support Person
NCT04006509
The United States Healthy Living Study
NCT03867409
Daily vs. Non-Daily SBRT for NSCLC
NCT03624907
Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction
NCT03564054
Villency-Proof of Action: Foot Device, Balance and Sway, Kinematics of Walking
NCT03663816
Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease
NCT03645031
The Absorption of Bioactive Berberine in Human
NCT03438292
Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine
NCT03527238
Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays
NCT02588326
Wearable Sensor for Responsive DBS for ET
NCT03051178
Enhancing School Safety Officers' Effectiveness Through Online Professional and Job Embedded Coaching
NCT03339648
Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas
NCT03334305
The Effect of Probiotic Intake on Intestinal Permeability in Healthy Adults
NCT03611400
LIPIDS-P Trial Phase I/II Trial
NCT03405870
Clinical Practice Guidelines for Neck and Low Back Pain in Outpatient Physical Therapy
NCT03523793
Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease
NCT03459079
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
NCT03207347
Wellness Achieved Through Changing Habits (The WATCH Study)
NCT03284788
Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)
NCT03396575
Spinal and Supra-Spinal Pain Mechanisms in Patients With Fibromyalgia
NCT03464292
Time to Eat Study - Pilot
NCT03590847
Pain Modulatory Profiles in Massage for Individuals With Neck Pain
NCT03534739
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
NCT03513328
Muscle Mass and Nutritional Risk in Older Adults
NCT03566758
Implementing Genomics in Practice (IGNITE): CYP2D6 Genotype-Guided Pain Management in Patients Undergoing Arthroplasty Surgery
NCT03534063
Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy
NCT03484039
Effects of Exenatide on Motor Function and the Brain
NCT03456687
Modifiable Work and Movement Solutions Low Back Pain in Seafood Workers
NCT03524378
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study
NCT03489863
Skeletal Muscle and Adipose Tissue Study
NCT03190668
Tobacco Use Treatment in Cancer Patients
NCT03482583
RHAPSody: Diagnostic Utility of RUSH Following ROSC
NCT03409289
Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint
NCT03232749
Pain Modulatory Profiles in Massage for Healthy Participants
NCT03490474
Health-Smart for Weight Loss at UF Jax Clinics
NCT03418701
Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI
NCT03437044
Web-Based Intervention Designed to Educate and Improve Adherence Through Learning to Use Continuous Glucose Monitoring
NCT03367351
RCT of Caloric Restriction vs. Alternate-Day Fasting in Non-Alcoholic Fatty Liver Disease
NCT03365531
Parent/Caregiver Conference Attendance Feasibility
NCT03432585
Effect of Diaphragm Stimulation During Surgery
NCT03303040
Peripheral Nerve Blocks for Above-the-knee Amputations
NCT03404180
Yoga for Psychological Distress in Gynecologic, Gastrointestinal, or Thoracic Cancer
NCT03385577
Therapeutic Oxygen for Gastrointestinal Atony (TOGA)
NCT03386136
Investigating the Impact of Multi-sensory Environments on Behavior During Assisted Bathing for Veterans With Dementia
NCT03303638
Music of Choice to Decrease Anxiety During Radiation Treatment
NCT03527225
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.